Registry for patients using CognivAiD for memory impairment and dementia
CognivAiD Real-World Evidence Clinical Registry
This study is collecting information from people with memory issues and dementia who are using CognivAiD to see how well it works and if there are any side effects in everyday situations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Moleac Pte Ltd. Industry-sponsored |
| Locations | 1 site (Singapore) |
| Trial ID | NCT06228638 on ClinicalTrials.gov |
What this trial studies
This observational registry collects data from patients who have been prescribed CognivAiD to evaluate its safety and effectiveness in real-world settings. It aims to reflect typical clinical practices by observing patients as they receive care, without assigning specific treatments. The registry will gather information on side effects, demographics, and treatment compliance to provide insights into the use of CognivAiD in diverse scenarios. Participation is voluntary, and the study includes a broad range of participants to enhance the generalizability of the findings.
Who should consider this trial
Good fit: Ideal candidates are adults who are currently prescribed or taking CognivAiD for memory impairment or dementia.
Not a fit: Patients who are not prescribed CognivAiD or are not experiencing memory impairment or dementia may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the real-world effectiveness of CognivAiD, potentially improving treatment strategies for memory impairment and dementia.
How similar studies have performed: While the safety and efficacy of CognivAiD have been established in clinical studies, this registry approach is relatively novel in assessing its real-world application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female * Legal age as per country requirement * Already taking or having to receive a prescription for CognivAiD (decision must have been made before consideration to participate in the registry) * Agrees to be included in the registry, provides written consent inclusion criteria * Male or female * Legal age as per country requirement * Already taking or having to receive a prescription for CognivAiD (decision must have been made before consideration to participate in the registry) * Agrees to be included in the registry, provides written consent, and allows retrieval and analysis of data by local requirements.
Where this trial is running
Singapore
- Raffles Hospital — Singapore, Singapore (Recruiting)
Study contacts
- Principal investigator: Narayanaswamy U Venketasubramanian, MD — Raffles Hospital
- Study coordinator: Sylvain Durrleman
- Email: sylvain.durrleman@moleac.com
- Phone: +33 677105764
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.